Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Strengthening through Wellness: Individual Preparation Achievement - 2Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
- 3Famous Rough terrain Vehicles for 2024
- 4This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
- 5What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US?
- Pick Your #1 game to observe
- Vote In favor of Your Favored Web-based Visual depiction Administration
- Most loved VR Game for Wellness: Which Keeps You Dynamic?
- ByHeart infant formula recall tied to botulism outbreak puts parents on edge
- IDF carried out mission to locate former hostage Avera Mengistu a day before Oct. 7
- 3 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 5 Advancement Developments in Biotechnology
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
